Search results

76 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
UNC and SAS join forces to personalize health care for better outcomes
Collaboration will leverage big data to help providers engage patients to manage diabetes, improve health
Located in News / 2013 / November
UNC begins clinical trial of EndoBarrier® for treatment of type 2 diabetes
The ENDO Trial is currently enrolling adults between the ages of 21 and 65 who have uncontrolled type 2 diabetes and are obese.
Located in News / 2013 / July
UNC Diabetes Care Center begins recruitment for long-term study of diabetes drug efficacy
Beginning recruitment in June, the project is called the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) Study. UNC will enroll patients at locations in Durham and Greensboro, N.C.
Located in News / 2013 / June
To test or not to test: Blood glucose monitoring for patients with type 2 diabetes
The Patient-Centered Outcomes Research Institute awards UNC School of Medicine researchers more than $2 million to study glucose monitoring in non-insulin treated patients living with type 2 diabetes.
Located in News / 2013 / May
Diabetes investigation in rats makes editor's pick in APS journal
An investigation into diabetes-related outcomes in a rat model, with senior author William Valdar, PhD, assistant professor of genetics at UNC, and first author Leah Solberg Woods, PhD, from the Medical College of Wisconsin, has made the editor's pick in this month's Physiological Genomics, a journal of the American Physiological Society.
Located in Vital Signs / 2013 / Feb. 7
UNC's Dr. John Buse named to international diabetes prize selection jury
The 2013 Harold Hamm International Prize for Biomedical Research in Diabetes encourages research focused on progress toward a cure.
Located in News / 2012 / November
Head-to-head trial of two diabetes drugs yields mixed results
Daily injections of liraglutide were slightly more effective than weekly injections of exenatide in lowering blood sugar and promoting weight loss. However, patients had fewer negative side effects on exenatide once weekly.
Located in News / 2012 / November
Three UNC specialties nationally ranked by U.S. News
Overall, eleven specialties at UNC Hospitals were recognized as nationally ranked or high performing by U.S. News & World Report in its annual "America's Best Hospitals" issue.
Located in News / 2012 / July
Antibodies reverse Type 1 diabetes in new immunotherapy study
Scientists at the University of North Carolina School of Medicine have used injections of antibodies to rapidly reverse the onset of Type I diabetes in mice genetically bred to develop the disease.
Located in News / 2012 / July
Join Dr. John Buse for live Facebook chat on diabetes
Dr. John Buse, director of the UNC Diabetes Care Center and chair of the National Diabetes Education Program, will host a live Facebook chat on diabetes management and prevention on Tuesday, May 22.
Located in News / 2012 / May